Ocular complications of chloroquine and derivatives therapy;Complicações oculares da terapêutica com a cloroquina e derivados

Arquivos Brasileiros de Oftalmologia

Volumn 73, Issue 4, 2010, Pages 384-389

  Lacava, Augusto Cézar ^a  

^a Instituto Internacional de Ciências Sociais   (Brazil)

Author keywords

Chloroquine adverse effects; Electroretinogram; Hydroxichloroquine adverse effects; Maculopathy chemically induced

Indexed keywords

ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; CHLOROQUINE; DRUG DERIVATIVE;

ARTICLE; DRUG EFFECT; HUMAN; RETINA; RETINA MACULA DEGENERATION; RISK FACTOR;

ANTIMALARIALS; ANTIRHEUMATIC AGENTS; CHLOROQUINE; HUMANS; MACULAR DEGENERATION; RETINA; RISK FACTORS;

EID: 78449242385     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/S0004-27492010000400019     Document Type: Article

References (36)

1. Wallace DJ. Antimalarial agents and lupus. Rheum Dis Clin North Am. 1994;20(1): 243-63. Review.
2. Gouveia EB, Morales MSA, Gouveia GB, Lourenzi VPM. Toxicidade ocular por derivados da 4-aminoquinolona. Arq Bras de Oftalmol. 2007;70(6):1046-51.
3. Ponchet MRNC, Vilela MAC, Sinahara KKS Dotto PF. Avaliação dos efeitos adversos desencadeados pelo uso de difosfato de cloroquina, com ênfase na retinotoxicida-de, em 350 doentes com lúpus eritematoso. An Bras Dermatol. 2005;80 (Supl 3):S275-82.
4. Rynes RI. Antimalarial drugs in the treatment of rheumatological diseases. Br J Rheumatol. 1997;36(7):799-805.
5. Comment in: Br J Rheumatol. 1998;37(5):580.
6. Rockwell DA. Psychiatric complications with chloroquine and quinacrine. Am J Psychiatry. 1968;124(9):1257-60.
7. Taylor WR, White NJ. Antimalarial drug toxicity: a review. Drug Saf. 2004;27(1):25-61. Review.
8. Fishman GA, Sokol S. Toxic conditions. In: Fishman GA, Sokol S. Electrophysiologic testing in disorders of the retina, optic nerve, and visual pathway. San Francisco: American Academy of Ophthalmology; c1990. p. 60-1.
9. Shinjo SK, Maia OO Jr, Tizziani VA, Morita C, Kochen JA, Takahashi WY, Laurindo IM. Chloroquine-induced bull's eye maculopathy in rheumatoid arthritis: related to disease duration? Clin Rheumatol. 2007;26(8):1248-53.
10. Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF; American Academy of Ophthalmology. Recommendations on screening for chloroquine and hidroxy-chloroquine retinopaty: a report by the American Academy of Ophthalmology. Ophthalmology. 2002;109(7):1377-82.
11. Goldhardt R, Corrêa ZMS, Eichenberg MC, Marcon IM, Vaccaro FilhoA. Avaliação da toxicidade ocular por derivados da 4-aminoquinolona. Arq Bras Oftalmol. 2002; 65(6):645-9.
12. Rüther K, Foerster J, Berndt S, Schroeter J. [Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses]. Ophthalmologe. 2007;104(10):875-9. German.
13. Mills PV, Beck M, Power BJ. Assessment of the retinal toxicity of hidroxychloro-quine. Trans Ophthalmol Soc U K. 1981;101(1):109-13.
14. Maturi RK, Folk JC, Nichols B, Oetting TT, Kardon RH. Hydroxychloroquine retino-pathy. Arch Ophthalmol. 1999;117(9):1262-3.
15. Lyons JS, Severns ML. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography. Am J Ophthalmol. 2007;143(5):801-9.
16. Moorty RS, Valluri S. Ocular toxicity associated with systemic drug therapy. Curr Opin Ophthalmol. 1999;10(6):438-46.
17. Falcone PM, Paolini L, Lou PL. Hydroxychloroquine toxicity despite normal dose therapy. Ann Ophthalmol. 1993;25(10):385-8.
18. Bonanomi MT, Dantas NC, Medeiros FA. Retinal nerve fibre layer thickness measurements in patients using chloroquine. Clin Experiment Ophthalmol. 2006;34(2):130-6.
19. Antunes DAL, Cavalcanti HD, Leal D, Santana HV, Santos RAV, Santos LPF. Alteração da camada de fibras nervosas da retina em usuários crônicos de cloroquina. Arq Bras Oftalmol. 2005;68(2):195-7.
20. Kellner U, Kellner S, Weinitz S. Chloroquine retinopathy: lipofucsin-and melanin-relatead fundus autofluorescence, optical coherence tomography and multifocal electroretinography. Doc Ophthalmol. 2008;116(2):119-27.
21. Fontaine F, Rougier MB, Korobelnik JF. Optical coherence tomography in hydro-xychloroquine retinopathy: two observational case reports. Retin Cases Brief Rep. 2007;1(3):131-3.
22. Raynes MF, Bhargava SK, Rosen ES. The blood-retinal barrier in chloroquine retinopathy. Invest Ophthalmol Vis Sci. 1989;30(8):1726-31.
23. Blomquist PH. Screening for hydroxychloroquine toxicity. Comp Ophthalmol Update. 2000;1:245-50.
24. Gass JDM. Stereoscopic atlas of macular diases: diagnosis and treatment. 2nd ed. Saint Louis: Mosby; 1977. p. 204-6.
25. Ingster-Moati I, Bui Quoc E, Crochet M, Orssaud C, Dufier JL, Roche O. Intoxication rétinienne sévère aux anti-paludéens de synthèse. J Fr Ophtalmol. 2006; 29(6):642-50.
26. Mahon GJ, Anderson HR, Gardiner TA, MacFarlane S, Archer DB, Stitt AW. Chloro-quine causes lysossomal disfunction in neural retina and RPE: implications for retinopathy. Curr Eye Res. 2004;28(4):277-84.
27. Ferreras A, Pinilla I, Abecia E, Pajarín AB, Honrubia FM. [Retinal toxicity following chloroquine therapy]. Arch Soc Esp Oftalmol. 2007;82(2):103-8. Spanish.
28. Bishara SA, Matamoros N. Evaluation of several tests in screening for chloroquine maculopathy. Eye (Lond). 1989;3(Pt 6):777-82.
29. Easterbrook M. Long-term course of antimalarial maculopathy after cessation of treatment. Can J Ophthalmol. 1992;27(5):237-9.
30. Lai Ty, Ngai JW, Chan WM, Lam DS. Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy. Doc Ophthalmol. 2006;112(3):177-87.
31. Levy GD, Munz SJ, Paschal J, Cohen HB, Pince KJ, Peterson T. Incidence of hidroxy-chloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice. Arthritis Rheum. 1997;40(8):1482-6.
32. Finbloom DS, Silver K, Newsome DA, Gunkel R. Comparison of hydroxychloro-quine and chloroquine use and the development of retinal toxicity. J Rheumatol. 1985;12(4):692-4.
33. Anyanwu EC, Kanu I, Nnadozie JB. Electrophysiological evaluation of adolescents presenting with chloroquine toxicity due to persistent malaria infections. Internet J Neurol. 2006;5(2). [cited 2010 July 14]. Available from: http://www.ispub.com/journal/the_internet_journal_of_neurology/archive/volume_5_number_2_19.htm
34. Drenckhahn D, Lüllmann-Rausch R. Drug-induced retinal lipidosis: differential susceptibilities of pigment epithelium and neuroretina toward several amphiphilic cationic drugs. Exp Mol Pathol. 1978;28(3):360-71.
35. Neubauer AS, Stiefelmeyer S, Berninger T, Arden GB, Rudolph G. The multifocal pathern electroretinogram in chloroquine retinopathy. Ophthalmic Res. 2004; 36(2):106-13.
36. Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nicolaou A, Kostopoulos C, Mavrikakis M. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology. 2003;110(7):1321-6.